Literature DB >> 30914210

Neutrophil Count Percentage and Neutrophil-Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired Pneumonia.

Jose Curbelo1, Olga Rajas2, Belén Arnalich3, José María Galván-Román1, Sergio Luquero-Bueno4, Mara Ortega-Gómez4, Angel Lancho3, Emilia Roy1, Ana Sánchez Azofra2, Gloria Mateo Jiménez3, Manuel Gómez5, Fernando Moldenhauer1, Javier Aspa6.   

Abstract

INTRODUCTION: Community-acquired pneumonia (CAP) is a common serious infection. This study aimed to evaluate the prognostic utility of neutrophil count percentage (NCP) and neutrophil-lymphocyte ratio (NLR) in patients with CAP.
METHODS: Retrospective study of hospitalized patients with CAP. Patients had a blood test at admission and 3-5 days after hospitalization (early-stage test). The main outcome variables were 30-day and 90-day mortality.
RESULTS: Two hundred and 9patients were included. Patients who survived had significant reductions in both NCP and NLR between admission and the day 3-5 blood tests (from 85.8% to 65.4% for NCP and from 10.1 to 3.2 for NLR). Twenty-five patients died in the first 90 days. Patients who died had lower, non-significant reductions in NCP (from 84.8% to 74%) and NLR (from 9.9 to 6.9) and significantly higher early-stage NCP and NLR than those who survived. NCP values higher than 85% and NLR values higher than 10 in the early-stage blood test were associated with a higher risk of mortality, even after multivariate adjustment (HR for NCP: 12; HR for NLR: 6.5).
CONCLUSION: NCP and NLR are simple, low-cost parameters with prognostic utility, especially when measured 3-5 days after CAP diagnosis. High NLR and/or NCP levels are associated with a greater risk of mortality at 90 days.
Copyright © 2019 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Biomarcadores; Biomarkers; Cociente neutrófilos/linfocitos; Community-acquired pneumonia; Neumonía adquirida en la comunidad; Neutrophil count percentage; Neutrophil-lymphocyte ratio; Porcentaje de neutrófilos

Mesh:

Year:  2019        PMID: 30914210     DOI: 10.1016/j.arbres.2019.02.005

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  9 in total

1.  Admission lysophosphatidylethanolamine acyltransferase level predicts the severity and prognosis of community-acquired pneumonia.

Authors:  Li Chen; Lili Zhao; Ying Shang; Yu Xu; Zhancheng Gao
Journal:  Infection       Date:  2021-03-10       Impact factor: 3.553

2.  Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study.

Authors:  Bei Mao; Yang Liu; Yan-Hua Chai; Xiao-Yan Jin; Hai-Wen Lu; Jia-Wei Yang; Xi-Wen Gao; Xiao-Lian Song; Hong Bao; An Wang; Wen-Chao Gu; Lei Zhao; Jie-Ping Pan; Fan Li; Tie-Feng Zhang; Ye-Chang Qian; Chun-Ling Du; Wei Ding; Chun-Lin Tu; De-Jie Chu; Chun Li; Ling Ye; Yong Luo; Cui-Xia Zheng; Rong-Huan Yu; Zhong-Min Qiu; Hui-Fang Cao; Jia-Wei Ren; Jing-Ya Zhao; Chang-Hui Wang; Hong-Zhou Lu; Jun Li; Yang Hu; Shuo Liang; Zhi-Jun Jie; Jie-Ming Qu; Jin-Fu Xu
Journal:  Lancet Digit Health       Date:  2020-05-14

3.  Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumonia.

Authors:  José María Galván-Román; Ángel Lancho-Sánchez; Sergio Luquero-Bueno; Lorena Vega-Piris; Jose Curbelo; Marcos Manzaneque-Pradales; Manuel Gómez; Hortensia de la Fuente; Mara Ortega-Gómez; Javier Aspa
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

4.  Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.

Authors:  Xue Wang; Xincheng Li; Yu Shang; Junwei Wang; Xiaona Zhang; Dongju Su; Shuai Zhao; Qin Wang; Lei Liu; Yupeng Li; Hong Chen
Journal:  Epidemiol Infect       Date:  2020-09-09       Impact factor: 2.451

5.  Developing the Pneumonia-Optimized Ratio for Community-acquired pneumonia: An easy, inexpensive and accurate prognostic biomarker.

Authors:  Vinícius Ferraz Cury; Lucas Quadros Antoniazzi; Paulo Henrique Kranz de Oliveira; Wyllians Vendramini Borelli; Sainan Voss da Cunha; Guilherme Cristianetti Frison; Enrico Emerim Moretto; Renato Seligman
Journal:  PLoS One       Date:  2021-03-23       Impact factor: 3.240

6.  Shen-Ling-Bai-Zhu-San Enhances the Antipneumonia Effect of Cefixime in Children by Ameliorating Gut Microflora, Inflammation, and Immune Response.

Authors:  Jinli Feng; Cheng Zhang; Houjun Chen; Ziliang Chen; Yongfeng Chen; Degen He; Qianyi Pan; Yongmao Zhou; Zhaoyang Chen; Xiaozheng Zhuang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-07       Impact factor: 2.650

7.  Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics.

Authors:  Zhichao Feng; Qizhi Yu; Shanhu Yao; Lei Luo; Wenming Zhou; Xiaowen Mao; Jennifer Li; Junhong Duan; Zhimin Yan; Min Yang; Hongpei Tan; Mengtian Ma; Ting Li; Dali Yi; Ze Mi; Huafei Zhao; Yi Jiang; Zhenhu He; Huiling Li; Wei Nie; Yin Liu; Jing Zhao; Muqing Luo; Xuanhui Liu; Pengfei Rong; Wei Wang
Journal:  Nat Commun       Date:  2020-10-02       Impact factor: 14.919

8.  Prognostic value of neutrophil- lymphocyte count ratio (NLCR) among adult ICU patients in comparison to APACHE II score and conventional inflammatory markers: a multi center retrospective cohort study.

Authors:  Tao Zhou; Nan Zheng; Xiang Li; Dongmei Zhu; Yi Han
Journal:  BMC Emerg Med       Date:  2021-02-23

9.  Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.

Authors:  Mai M Aly; Taghreed S Meshref; Marwa A Abdelhameid; Shimaa A Ahmed; Asmaa S Shaltout; Alaa Eldin Abdel-Moniem; Dina A Hamad
Journal:  J Blood Med       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.